Researcher Portfolio
Rohrbach, Marcus
Computer Vision and Multimodal Computing, MPI for Informatics, Max Planck Society, International Max Planck Research School, MPI for Informatics, Max Planck Society
Researcher Profile
Position: Computer Vision and Multimodal Computing, MPI for Informatics, Max Planck Society
Position: International Max Planck Research School, MPI for Informatics, Max Planck Society
Researcher ID: https://pure.mpg.de/cone/persons/resource/persons45307
Publications
(1 - 25 of 43)
: Jaumdally, S., Tomasicchio, M., Pooran, A., Esmail, A., Kotze, A., Meier, S., Wilson, L., Oelofse, S., van der Merwe, C., Roomaney, A., Davids, M., Suliman, T., Joseph, R., Perumal, T., Scott, A., Shaw, M., Preiser, W., Williamson, C., Goga, A., Mayne, E., Gray, G., Moore, P., Sigal, A., Limberis, J., Metcalfe, J., & Dheda, K. (2024). Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants. Nature Communications, 15(1): 2003. doi:10.1038/s41467-024-45400-1. [PubMan] : Krause, R. G. E., Moyo-Gwete, T., Richardson, S. I., Makhado, Z., Manamela, N. P., Hermanus, T., Mkhize, N. N., Keeton, R., Benede, N., Mennen, M., Skelem, S., Karim, F., Khan, K., Riou, C., Ntusi, N. A. B., Goga, A., Gray, G., Hanekom, W., Garrett, N., Bekker, L.-G., Groll, A., Sigal, A., Moore, P. L., Burgers, W. A., & Leslie, A. (2023). Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells. NPJ Vaccines, 8(1). doi:10.1038/s41541-023-00724-9. [PubMan] : Naicker, N., Rodel, H., Perumal, R., Ganga, Y., Bernstein, M., Benede, N., Karim, S. A., Padayacthi, N., Sigal, A., & Naidoo, K. (2023). Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb. Infect Drug Resist, 16:3629-3638. doi:10.2147/IDR.S401403. [PubMan] : Hysenaj, L., Little, S., Kulhanek, K., Magnen, M., Bahl, K., Gbenedio, O. M., Prinz, M., Rodriguez, L., Andersen, C., Rao, A. A., Shen, A., Lone, J.-C., Lupin-Jimenez, L. C., Bonser, L. R., Serwas, N. K., Mick, E., Khalid, M. M., Taha, T. Y., Kumar, R., Li, J. Z., Ding, V. W., Matsumoto, S., Maishan, M., Sreekumar, B., Simoneau, C., Nazarenko, I., Tomlinson, M. G., Khan, K., von Gottberg, A., Sigal, A., Looney, M. R., Fragiadakis, G. K., Jablons, D. M., Langelier, C. R., Matthay, M., Krummel, M., Erle, D. J., Combes, A. J., Sil, A., Ott, M., Kratz, J. R., & Roose, J. P. (2023). SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants. Stem Cell Reports, 18(3), 636-653. doi:10.1016/j.stemcr.2023.01.011. [PubMan] : Tan, C. W., Chia, W. N., Zhu, F., Young, B. E., Chantasrisawad, N., Hwa, S.-H., Yeoh, A.-Y.-Y., Lim, B. L., Yap, W. C., Pada, S. K. M. S., Tan, S. Y., Jantarabenjakul, W., Toh, L. K., Chen, S., Zhang, J., Mah, Y. Y., Chen, V.-C.-W., Chen, M.-I.-C., Wacharapluesadee, S., Sigal, A., Putcharoen, O., Lye, D. C., & Wang, L.-F. (2022). SARS-CoV-2 Omicron variant emerged under immune selection. Nature Microbiology, 7(11), 1756-1761. doi:10.1038/s41564-022-01246-1. [PubMan] : Krause, R., Snyman, J., Shi-Hsia, H., Muema, D., Karim, F., Ganga, Y., Ngoepe, A., Zungu, Y., Gazy, I., Bernstein, M., Khan, K., Mazibuko, M., Mthabela, N., Ramjit, D., COMMIT-KZN Team, Limbo, O., Jardine, J., Sok, D., Wilson, I. A., Hanekom, W., Sigal, A., Kløverpris, H., Ndung'u, T., & Leslie, A. (2022). HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway. eLife, e79924. doi:10.7554/eLife.79924. [PubMan] : Snyman, J., Hwa, S. H., Krause, R., Muema, D., Reddy, T., Ganga, Y., Karim, F., Leslie, A., Sigal, A., Ndung'u, T., & COMMIT-KZN Team (2022). Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave. Clinical Infectious Diseases, 75(1). doi:10.1093/cid/ciab758. [PubMan] : Hwa, S.-H., Snyman, J., Bernstein, M., Ganga, Y., Cele, S., Muema, D., Tan, C. W., Khan, K., Karim, F., Hanekom, W., Bernstein, L., Kaufmann, S. H. E., Wang, L.-F., Ndung'u, T., & Sigal, A. (2022). HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization. The Journal of Infectious Diseases. doi:10.1093/infdis/jiac343. [PubMan] : Hwa, h.-H., Snyman, J., Bernstein, M., Ganga, Y., Cele, S., Muema, D., Tan, C. W., Khan, K., Karim, F., Hanekom, W., Bernstein, L., Kaufmann, S. H. E., Wang, L.-F., Ndung’u, T., Sigal, A., & COMMIT-KZN Team (2022). Association Between Human Immunodeficiency Virus Viremia and compromised Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant. The Journal of Infectious Diseases. [PubMan] : Khan, K., Karim, F., Ganga, Y., Bernstein, M., Jule, Z., Reedoy, K., Cele, S., Lustig, G., Amoako, D., Wolter, N., Samsunder, N., Sivro, A., San, J. E., Giandhari, J., Tegally, H., Pillay, S., Naidoo, Y., Mazibuko, M., Miya, Y., Ngcobo, N., Manickchund, N., Magula, N., Karim, Q. A., von Gottberg, A., Karim, S. S. A., Hanekom, W., Gosnell, B. I., Team, C.-K., Lessells, R. J., de Oliveira, T., Moosa, M.-Y.-S., & Sigal, A. (2022). Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nature Communications, 13(1): 4686. doi:10.1038/s41467-022-32396-9. [PubMan] : Greaney, A. J., Eguia, R. T., Starr, T. N., Khan, K., Franko, N., Logue, J. K., Lord, S. M., Speake, C., Chu, H. Y., Sigal, A., & Bloom, J. D. (2022). The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes. PLoS Pathogens, 18(6): e1010592. doi:10.1371/journal.ppat.1010592. [PubMan] : Khan, K., Karim, F., Cele, S., Reedoy, K., San, J. E., Lustig, G., Tegally, H., Rosenberg, Y., Bernstein, M., Jule, Z., Ganga, Y., Ngcobo, N., Mazibuko, M., Mthabela, N., Mhlane, Z., Mbatha, N., Miya, Y., Giandhari, J., Ramphal, Y., Naidoo, T., Sivro, A., Samsunder, N., Kharsany, A. B. M., Amoako, D., Bhiman, J. N., Manickchund, N., Karim, Q. A., Magula, N., Karim, S. S. A., Gray, G., Hanekom, W., von Gottberg, A., Team, C.-K., Milo, R., Gosnell, B. I., Lessells, R. J., Moore, P. L., de Olveira, T., Moosa, M.-Y.-S., & Sigal, A. (2022). Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature. doi:10.1038/s41586-022-04830-x. [PubMan] : Sigal, A., Milo, R., & Jassat, W. (2022). Estimating disease severity of Omicron and Delta SARS-CoV-2 infections COMMENT. Nature Reviews Immunology, 22(5), 267-269. doi:10.1038/s41577-022-00720-5. [PubMan] : Reuschl, A.-K., Mesner, D., Shivkumar, M., Whelan, M. V. X., Pallett, L. J., Guerra-Assunção, J. A., Madansein, R., Dullabh, K. J., Sigal, A., Thornhill, J. P., Herrera, C., Fidler, S., Noursadeghi, M., Maini, M. K., & Jolly, C. (2022). HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells. Cell Reports, 39(2): 110650. doi:10.1016/j.celrep.2022.110650. [PubMan] : Scheepers, C., Everatt, J., Amoako, D. G., Tegally, H., Wibmer, C. K., Mnguni, A., Ismail, A., Mahlangu, B., Lambson, B. E., Martin, D. P., Wilkinson, E., San, J. E., Giandhari, J., Manamela, N., Ntuli, N., Kgagudi, P., Cele, S., Richardson, S. I., Pillay, S., Mohale, T., Ramphal, U., Naidoo, Y., Khumalo, Z. T., Kwatra, G., Gray, G., Bekker, L.-G., Madhi, S. A., Baillie, V., Voorhis, W. C. V., Treurnicht, F. K., Venter, M., Mlisana, K., Wolter, N., Sigal, A., Williamson, C., Hsiao, N.-Y., Msomi, N., Maponga, T., Preiser, W., Makatini, Z., Lessells, R., Moore, P. L., de Oliveira, T., von Gottberg, A., & Bhiman, J. N. (2022). Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage. Nature Communications, 13(1): 1976. doi:10.1038/s41467-022-29579-9. [PubMan] : Sigal, A., Milo, R., & Jassat, W. (2022). Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nature Reviews Immunology, 22, 267-269. doi:10.1038/s41577-022-00720-5. [PubMan] : Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., Amoako, D. G., Karim, F., Bernstein, M., Lustig, G., Archary, D., Smith, M., Ganga, Y., Jule, Z., Reedoy, K., Hwa, S.-H., Giandhari, J., Blackburn, J. M., Gosnell, B. I., Karim, S. S. A., Hanekom, W., NGS-SA, COMMIT-KZN Team, von Gottberg, A., Bhiman, J. N., Lessells, R. J., Moosa, M.-Y.-S., Davenport, M. P., de Oliveira, T., Moore, P. L., & Sigal, A. (2022). Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature, 602, 654-656. doi:10.1038/s41586-021-04387-1. [PubMan] : Cele, S., Karim, F., Lustig, G., San, J. E., Hermanus, T., Tegally, H., Snyman, J., Moyo-Gwete, T., Wilkinson, E., Bernstein, M., Khan, K., Hwa, S.-H., Tilles, S. W., Singh, L., Giandhari, J., Mthabela, N., Mazibuko, M., Ganga, Y., Gosnell, B. I., Karim, S. S. A., Hanekom, W., Voorhis, W. C. V., Ndung'u, T., Team, C.-K., Lessells, R. J., Moore, P. L., Moosa, M.-Y.-S., de Oliveira, T., & Sigal, A. (2022). SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host & Microbe, 30(2). doi:10.1016/j.chom.2022.01.005. [PubMan] : Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., Zepeda, S. K., Papa, G., Kemp, S. A., Ikeda, T., Toyoda, M., Tan, T. S., Kuramochi, J., Mitsunaga, S., Ueno, T., Shirakawa, K., Takaori-Kondo, A., Brevini, T., Mallery, D. L., Charles, O. J., Collaboration, C.-N.-B.-C.-., Japan, G. t. P., Consortium, E.-C., Bowen, J. E., Joshi, A., Walls, A. C., Jackson, L., Martin, D., Smith, K. G. C., Bradley, J., Briggs, J. A. G., Choi, J., Madissoon, E., Meyer, K., Mlcochova, P., Ceron-Gutierrez, L., Doffinger, R., Teichmann, S. A., Fisher, A. J., Pizzuto, M. S., de Marco, A., Corti, D., Hosmillo, M., Lee, J. H., James, L. C., Thukral, L., Veesler, D., Sigal, A., Sampaziotis, F., Goodfellow, I. G., Matheson, N. J., Sato, K., & Gupta, R. K. (2022). Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature, 603(7902), 706-714. doi:10.1038/s41586-022-04474-x. [PubMan] : Keeton, R., Tincho, M. B., Ngomti, A., Baguma, R., Benede, N., Suzuki, A., Khan, K., Cele, S., Bernstein, M., Karim, F., Madzorera, S. V., Moyo-Gwete, T., Mennen, M., Skelem, S., Adriaanse, M., Mutithu, D., Aremu, O., Stek, C., du Bruyn, E., Mescht, M. A. V. D., de Beer, Z., de Villiers, T. R., Bodenstein, A., van den Berg, G., Mendes, A., Strydom, A., Venter, M., Giandhari, J., Naidoo, Y., Pillay, S., Tegally, H., Grifoni, A., Weiskopf, D., Sette, A., Wilkinson, R. J., de Oliveira, T., Bekker, L.-G., Gray, G., Ueckermann, V., Rossouw, T., Boswell, M. T., Bihman, J., Moore, P. L., Sigal, A., Ntusi, N. A. B., Burgers, W. A., & Riou, C. (2022). T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature, 603, 488-492. doi:10.1038/s41586-022-04460-3. [PubMan] : Sigal, A. (2022). Milder disease with Omicron: is it the virus or the pre-existing immunity? Nature Reviews Immunology. doi:10.1038/s41577-022-00678-4. [PubMan] : Rodel, H. E., Ferreira, I. A. T. M., Ziegler, C. G. K., Ganga, Y., Bernstein, M., Hwa, S.-H., Nargan, K., Lustig, G., Kaplan, G., Noursadeghi, M., Shalek, A. K., Steyn, A. J. C., & Sigal, A. (2021). Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response. Frontiers in Microbiology, 12: 757134. doi:10.3389/fmicb.2021.757134. [PubMan] : Kolloli, A., Kumar, R., Singh, P., Narang, A., Kaplan, G., Sigal, A., & Subbian, S. (2021). Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology. Commun Biol., 4(1). doi:10.1038/s42003-021-02769-9. [PubMan] : Karim, F., Gazy, I., Cele, S., Zungu, Y., Krause, R., Bernstein, M., Khan, K., Ganga, Y., Rodel, H., Mthabela, N., Mazibuko, M., Muema, D., Ramjit, D., Ndung'u, T., Hanekom, W., Gosnell, B., COMMIT-KZN Team, Lessells, R. J., Wong, E. B., de Oliveira, T., Moosa, M.-Y.-S., Lustig, G., Leslie, A., Kløverpris, H., & Sigal, A. (2021). HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave. eLife, 10: e67397. doi:10.7554/eLife.67397. [PubMan] : Lustig, G., Cele, S., Karim, F., Derache, A., Ngoepe, A., Khan, K., Gosnell, B. I., Moosa, M.-Y.-S., Ntshuba, N., Marais, S., Jeena, P. M., Govender, K., Adamson, J., Kløverpris, H., Gupta, R. K., Harrichandparsad, R., Patel, V. B., & Sigal, A. (2021). T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy. PLoS Pathogens, 9: e1009871. doi:10.1371/journal.ppat.1009871. [PubMan]